Skip to main content

Insulet

By Jessica Hagen | 01:38 pm | February 15, 2023
Tasso received a CE Mark for its blood collection device, and MindMaze launched Izar, a smart peripheral to help improve a user's hand motor function.   
By Jessica Hagen | 03:20 pm | February 13, 2023
The Omnipod maker purchased assets related to Bigfoot Biomedical's pump-based automated insulin delivery technology.
By Jessica Hagen | 01:38 pm | January 24, 2023
The data breach occurred when the company requested users acknowledge they had received a notice about a recall of the Omnipod DASH Insulin Management System.
By Jessica Hagen | 01:58 pm | November 17, 2022
The Class I recall of the DASH system comes days after the company issued a voluntary urgent medical device "correction" for its Omnipod 5 controller.
By Jessica Hagen and Emily Olsen | 02:08 pm | November 08, 2022
Amwell, Hims & Hers, Insulet and Butterfly Network also post third quarter results.  
By Emily Olsen | 01:48 pm | May 06, 2022
Also: Butterfly Network reports a year-over-year revenue increase of more than 25%, with a $44.5 million net loss, and One Medical announces a significant jump in revenue.
By Emily Olsen | 03:17 pm | January 31, 2022
The pump currently integrates with the Dexcom G6 CGM and can be worn for up to 72 hours.
By Jonah Comstock | 04:43 pm | February 20, 2020
Both CGM competitors announced integrations with Insulet yesterday during the Advanced Technologies & Treatment for Diabetes Congress in Madrid.
By Dave Muoio | 11:33 am | November 07, 2018
The Omnipod Dash Insulin Management System will integrate with Samsung personal devices.
By Laura Lovett | 01:56 pm | June 04, 2018
Billerica, Massachusetts-based Insulet Corporation, maker of the OmniPod Insulin pump, has just announced that it received the FDA clearance to commercialize its latest product the Omnipod Dash Insulin Management System.